Evidence map›Paper›PMID 31600854›Full record

ArticleMolecular oncology2019

Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.

Ling Lu, Ruting Xie, Rong Wei, Chunmiao Cai, Dexi Bi, Dingzi Yin, Hu Liu, Jiayi Zheng, Youhua Zhang, Feifei Song and 4 more

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. MedComm · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Integrin α5 silencing inhibits proliferation, invasion and metastasis of human liver cancer Bel-7404 cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Ling LuDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Ruting XieDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Rong WeiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Chunmiao CaiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Dexi BiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Dingzi YinDepartment of Gastrointestinal Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Hu LiuDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Jiayi ZhengDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Youhua ZhangDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Feifei SongDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Yaohui GaoDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Linhua TanDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Qing WeiDepartment of Pathology, Shanghai Tenth People's Hospital Affiliated to Tongji University, China.
Huanlong QinDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-3956-7595
Tongji University · CNUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumorigenesis of colorectal cancer (CRC) is a complicated process, involving interactions between cancer cells and the microenvironment. The role of α5 integrin subunit in CRC remains controversial, and previous studies mainly focused on cancer cells. Herein, we report an important role of α5 in stroma fibroblasts in the tumorigenesis of CRC. The expression of α5 was found to be located in colorectal tumor stroma rather than in epithelia cancer cells. Immunofluorescence colocalization and gene correlation analysis confirmed that α5 was mainly expressed in cancer-associated fibroblasts (CAFs). Moreover, experimental evidence showed that α5 expression was required for the tumor-promoting effect of fibroblast cells. In an in vivo xenograft nude mice model, α5 depletion in fibroblasts dramatically suppressed fibroblast-induced tumor growth. In an in vitro cell coculture assay, α5 depletion or knockdown reduced the ability of fibroblasts to promote cancer cell migration and invasion compared with wild-type fibroblasts; moreover, we observed that the expression and assembly of fibronectin were downregulated after α5 depletion or knockdown in fibroblasts. Analysis of the RNA-Seq data of the Cancer Genome Atlas cohort revealed that high expression of ITGA5 (α5 integrin subunit) was correlated with poor overall survival in colorectal adenocarcinoma, which was further confirmed by immunohistochemistry in an independent cohort of 355 patients. Thus, our study identifies α5 integrin subunit as a novel stroma molecular marker for colorectal adenocarcinoma, offers a fresh insight into colorectal adenocarcinoma progression, and shows that α5 expression in stroma fibroblasts underlies its ability to promote the tumorigenesis of colorectal adenocarcinoma.

Indexed as

AdenocarcinomaBiomarkers, TumorCancer-Associated FibroblastsCarcinogenesisColorectal NeoplasmsIntegrinsNeoplasm ProteinsAnimalsCell Line, TumorFemaleHumansMaleMiceMice, NudeNeoplasm InvasivenessBiomarkers, TumorIntegrinsITGA5 protein, humanNeoplasm Proteinscolorectal adenocarcinomafibroblaststumor stromaα5 integrin subunit

Identifiers

PMID31600854
PMCPMC6887586
OpenAlexW2980009698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.